Eugia Steriles' Injectable Facility Gets FDA Approval

By By Rediff Money Desk, Hyderabad
Sep 11, 2024 14:23
Eugia Steriles's new injectables facility in Andhra Pradesh has received its first product approval from the US FDA, marking a significant milestone for the company.
Hyderabad, Sep 11 (PTI) Aurobindo Pharma Ltd on Wednesday said a new injectable facility of Eugia Steriles Private Limited which was inspected by the US Food and Drug Administration (FDA) received its first product approval.

Eugia Steriles Private Limited is a 100 per cent subsidiary of Eugia Pharma Specialities Limited and a step-down subsidiary of Aurobindo Pharma.

A press release from the drugmaker said the plant located in Andhra Pradesh was inspected by the US regulator from March 28 to April 5, this year.

The FDA approved Lidocaine Hydrochloride Injection, USP, 1% (10 mg/mL) and 2% (20 mg/mL).

The sANDA (supplemental Abbreviated New Drug Application) for the product was submitted as "Prior Approval Supplement" for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility.
Source: PTI
Read More On:
andhra pradeshaurobindo pharmainjectable facilityfda approvaleugia steriles
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

MIP to Counter Chinese Price Cuts: BDMA Asks...

Bulk drug makers urge Centre to expedite MIP implementation to combat predatory Chinese...

Nepal Allows Indian High-Value Notes After Ban

Nepal lifts decade-long ban on Indian high-value currency notes (Rs 200 & Rs 500) up to...

SBI Yono 2.0 Launched; Hiring 10,000 Staff

SBI launches Yono 2.0 & plans to hire 10,000 staff to help customers migrate to digital...

Ravi Ranjan Appointed SBI MD

Ravi Ranjan appointed Managing Director of State Bank of India (SBI). He succeeds Vinay...

KSH International IPO: Rs 213 Cr from Anchor...

KSH International raises Rs 213 cr from anchor investors ahead of its IPO. IPO opens...

NCDEX Gets Sebi Nod for Mutual Fund Platform

NCDEX receives Sebi approval for mutual fund platform, paving the way for equity...

WhatsApp Data Sharing: NCLAT Clarifies User...

NCLAT mandates user consent for WhatsApp data collection, including advertising. Learn...

Pajson Agro IPO Subscribed 6.59 Times on Day 3

Pajson Agro India''s Rs 74.4-cr SME IPO subscribed 6.59 times on final day. IPO...

Battery Storage Cost Falls: Rs 2.1/Unit, Power Min

Battery energy storage (BESS) cost drops to Rs 2.1/unit from Rs 10.18 in 2022-23....

India Rice Exports to US: No Dumping, Says...

Commerce Secretary clarifies India exports expensive basmati rice to the US, refuting...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com